NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹1,359 Cr | ₹1,013 Cr | ₹765 Cr | ₹472 Cr | ₹312 Cr |
What is the latest Appropriations of NEULAND LABORATORIES ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹1,359 Cr |
| Mar2025 | ₹1,013 Cr |
| Mar2024 | ₹765 Cr |
| Mar2023 | ₹472 Cr |
| Mar2022 | ₹312 Cr |
How is Appropriations of NEULAND LABORATORIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,359 Cr | 34.17 | |
| Mar2025 | ₹1,013 Cr | 32.31 | |
| Mar2024 | ₹765 Cr | 62.26 | |
| Mar2023 | ₹472 Cr | 51.18 | |
| Mar2022 | ₹312 Cr | - | |
Compare Appropriations of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹27,731.5 Cr | 2.3% | -4.5% | 51.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 2.3% |
-4.5% |
51.6% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses